Drug intelligence / Profile preview

tartary buckwheat

Development stage
Preclinical
Lead developer
Big Bold Health
Modality
Small Molecules
Administration
Oral
01

Overview

Tartary buckwheat (Fagopyrum tataricum) is a plant cultivated primarily in the Himalayas and parts of China. It is not a true cereal grain but is used similarly to grains for food and as a dietary supplement. Tartary buckwheat is especially rich in polyphenols such as rutin and quercetin—antioxidants that may help neutralize free radicals and reduce oxidative stress. These compounds are associated with potential anti-inflammatory effects, immune modulation, cardiovascular support (by improving blood vessel function and lowering LDL cholesterol), blood sugar regulation (by improving insulin sensitivity), and possible neuroprotective benefits. The plant also contains vitamins (notably B vitamins), minerals like magnesium, sulfur-containing amino acids, glycine, arginine, dietary fiber, d-chiro-inositol (DCI), and other nutrients[2][4][6]. While traditionally used in Chinese medicine for detoxification and liver protection[6], modern research suggests possible benefits for diabetes management by slowing carbohydrate breakdown into sugar[1][2], supporting heart health[2], alleviating chronic venous insufficiency symptoms[3], reducing fatigue[5], and potentially protecting against memory impairment via its high rutin content[6]. However, robust clinical evidence supporting these uses remains limited.

Brand names
Himalayan Tartary BuckwheatHTB
Other names
tartary buckwheatFagopyrum tataricumPolygonum tataricumHimalayan Tartary BuckwheatHTB
02

Targets

Buckwheat 13S globulinBuckwheat 2S albuminXO (Xanthine Oxidoreductase)

Beyond the preview

Go deeper on tartary buckwheat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tartary buckwheat.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call